Clinical trial
Double Blind Placebo Controlled Trial of Anticonvulsant Effects of n-3 PUFAs in Human Subjects With Epilepsy
NCT01769092 is registered in ClinicalTrials.gov with The Canadian College of Naturopathic Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Double Blind Placebo Controlled Trial of Anticonvulsant Effects of n-3 PUFAs in Human Subjects With Epilepsy
- Lead sponsor
- The Canadian College of Naturopathic Medicine
- Phase
- Phase 2/3
- Overall status
- Terminated
- Start date
- January 31, 2013
- Completion date
- January 31, 2020
- Enrollment
- 6 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
epilepsy (treatment refractory)